Press release - 18/06/2025 Hector Foundation Prize 2025 for Annika Reinke: “Metrics Reloaded” improves the quality of AI-supported image analysis Computer scientist Annika Reinke from the German Cancer Research Center (DKFZ) has been awarded the Hector Foundation Prize 2025, endowed with €10,000, for her outstanding work in the field of AI-supported medical image analysis. She received the award for the project Metrics Reloaded, which can significantly improve the quality and reliability of AI-supported image analysis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hector-foundation-prize-2025-annika-reinke-metrics-reloaded-improves-quality-ai-supported-image-analysis
Save the date - 13/11/2025 - 14/11/2025 Trinational HealthTech Days 2025 Basel, Switzerland and online, Networking event https://www.gesundheitsindustrie-bw.de/en/event/trinational-healthtech-days-2025
Save the date - 11/05/2026 - 13/05/2026 The MedTech Forum 2026 Stockholm, Sweden, Conference https://www.gesundheitsindustrie-bw.de/en/event/medtech-forum-2026
Press release - 12/06/2025 BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer Acquisition will strengthen the mRNA-based cancer immunotherapy candidates, marking BioNTech’s milestone in its oncology strategy. Acquisition of CureVac will complement BioNTech’s capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturing. All-stock acquisition has potential to create value for both companies’ shareholders given their complementary capabilities, focus on mRNA, and shared vision.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biontech-announces-strategic-transaction-acquire-curevac-public-exchange-offer
Event - 06/11/2025 The TechMed Event 2025 Netherlands, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/techmed-event-2025
Press release - 25/06/2025 Otto Hahn Medal for Jonas Wilhelm For his outstanding achievements in his doctorate at the interface between chemistry and biology, Jonas Wilhelm is awarded an Otto Hahn Medal 2025 by the Max Planck Society. He wrote his thesis in the department Chemical Biology of Kai Johnsson at the Max Planck Institute for Medical Research. In his doctorate, Jonas Wilhelm developed a molecular tool, a biosensor that records and permanently stores biological activities at the cellular level.https://www.gesundheitsindustrie-bw.de/en/article/press-release/otto-hahn-medal-jonas-wilhelm
Computer tool opens up new ways to address antibiotic resistance - 02/07/2025 PhARIS identifies effective phages against multi-resistant bacteria Bacteriophages - viruses that specifically attack and destroy bacteria - are emerging as promising alternatives to antibiotics in the fight against drug-resistant infections. To speed this effort, researchers have created PhARIS, a computational tool that mines genomic data to pinpoint phages that are effective against S. aureus. By rapidly matching phage and pathogen, PhARIS can accelerate the development of targeted phage therapies.https://www.gesundheitsindustrie-bw.de/en/article/news/pharis-identifies-effective-phages-against-multi-resistant-bacteria
Event - 09/07/2025 - 10/07/2025 Medical Technology Germany 2025 Ulm, Messe https://www.gesundheitsindustrie-bw.de/en/event/medical-technology-germany-2025
Press release - 27/06/2025 Felix Glang receives Otto Hahn Medal Felix Glang, of the Max Planck Institute for Biological Cybernetics in Tübingen, has been awarded the Otto Hahn Medal in recognition of his achievements in developing new magnetic resonance imaging (MRI) methods. Glang's methods enable clearer and faster brain scans.https://www.gesundheitsindustrie-bw.de/en/article/press-release/felix-glang-receives-otto-hahn-medal
Press release - 04/07/2025 Breakthrough in Artificial Blood Production Scientists have been working on the artificial production of blood for several decades. Making a new discovery, researchers from the Institute for Cellular Biology and Immunology Thurgau at the University of Konstanz, in collaboration with Queen Mary University of London, have come an important step closer to this goal.https://www.gesundheitsindustrie-bw.de/en/article/press-release/breakthrough-artificial-blood-production
Press release - 09/07/2025 The evolution of cancer cells decoded Cancer can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research Center have now developed a method that allows for the first time to reconstruct the temporal development—the evolution—of cancerous cells from a single tissue sample. https://www.gesundheitsindustrie-bw.de/en/article/press-release/evolution-cancer-cells-decoded
Event - 24/09/2025 smartLabs Summit 2025 – Optimise your workflow Heidelberg, Summit https://www.gesundheitsindustrie-bw.de/en/event/smartlabs-summit-2025-optimise-your-workflow
Press release - 09/07/2025 A new drug target for treating cancer and viral infections An international team of researchers led by Konstanz biologists has identified a molecular mechanism that regulates the activity of N-myristoyltransferases. This enzyme plays a role in biological signalling pathways, where dysregulation can lead to serious illness.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-drug-target-treating-cancer-and-viral-infections
Press release - 10/07/2025 Investigating kinase activity in living cells The ability of protein kinases to transfer a phosphate group to target proteins plays an important role in many cellular processes. Scientists at the Max Planck Institute for Medical Research have now developed a novel molecular tool that can monitor these kinase activities both spatially and temporally. This makes it possible to investigate the link between kinase activities and cellular phenotypes in heterogenous cell populations and in vivo.https://www.gesundheitsindustrie-bw.de/en/article/press-release/investigating-kinase-activity-living-cells
Press release - 03/07/2025 Focus on Muscle Metabolism: Sex Differences in Sport and Obesity The skeletal muscles of men and women process glucose and fats in different ways. A study provides the first comprehensive molecular analysis of these differences. The results possibly give an explanation why metabolic diseases such as diabetes manifest differently in women and men – and why they respond differently to physical activity. https://www.gesundheitsindustrie-bw.de/en/article/press-release/focus-muscle-metabolism-sex-differences-sport-and-obesity
Press release - 08/07/2025 Five million euros for research into early cancer detection Investing in a healthier future: The HORNBACH Group is supporting the new National Cancer Prevention Center in Heidelberg with a donation of five million euros. In the future, a new laboratory will conduct research into more effective early detection and screening methods.https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-million-euros-research-early-cancer-detection
Press release - 02/07/2025 Commission launches new strategy to make Europe a global leader in life sciences by 2030 The European Commission has launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030. Life sciences – the study of living systems, from cells to ecosystems – are central to our health, environment and economy. They drive innovation in medicine, food and sustainable production, adding nearly €1.5 trillion in value to the EU economy and supporting 29 million jobs across the Union.https://www.gesundheitsindustrie-bw.de/en/article/press-release/commission-launches-new-strategy-make-europe-global-leader-life-sciences-2030
Event - 07/07/2027 - 08/07/2027 Curious2027 – Future Insight™ Conference Heidelberg and online, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/curious2027-future-insighttm-conference
BIOPRO is the central point of contact for all matters relating to the life sciences General Projects https://www.bio-pro.de/en/projects/general-projects
Press release - 11/07/2025 Molecular arms race: How the genome defends itself against internal enemies An international research team has deciphered a mechanism of evolutionary arms race in human cells. The findings provide insights into how mobile elements in DNA hijack cellular functions – and how cells can defend themselves against this in order to prevent conditions such as tumour formation or chronic inflammation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-arms-race-how-genome-defends-itself-against-internal-enemies
Press release - 11/07/2025 Cellular stress response – researchers discover potential therapeutic target for heart failure Researchers at the German Centre for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of heart failure that has so far been difficult to treat.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cellular-stress-response-researchers-discover-potential-therapeutic-target-heart-failure
Press release - 14/07/2025 Faster and brighter protein labeling with new tool SNAP-tag2 The protein SNAP-tag is a powerful tool for labeling proteins with synthetic fluorophores for bioimaging. Scientists at the Max Planck Institute for Medical Research in Heidelberg have engineered a much improved version named SNAP-tag2 as well as optimized substrates for faster labeling in live cells.https://www.gesundheitsindustrie-bw.de/en/article/press-release/faster-and-brighter-protein-labeling-new-tool-snap-tag2
Press release - 15/07/2025 ERC funding for research into improved cancer immunotherapies With its Proof of Concept grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research results. Two scientists from the German Cancer Research Center (DKFZ) have now received this coveted funding for the second time.https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-funding-research-improved-cancer-immunotherapies
AI-supported image recognition accelerates identification of zebrafish mutants - 16/07/2025 EmbryoNet AI automatically identifies developmental disorders In complex organisms, embryonic development is tightly regulated by intricate signalling pathways. When these pathways are disrupted, they can lead to characteristic developmental defects that are not easy to detect with the naked eye. Developmental biologist Prof. Dr. Patrick Müller from the University of Konstanz has developed EmbryoNet, an AI-powered software tool that uses image analysis to reliably identify such developmental disorders.https://www.gesundheitsindustrie-bw.de/en/article/news/embryonet-ai-automatically-identifies-developmental-disorders
Press release - 16/07/2025 Unexpected side-effect: how common medications clear the way for pathogens Study led by the University of Tübingen: many non-antibiotics weaken the natural protective function of the intestine – with consequences for the colonization with pathogenic bacteriahttps://www.gesundheitsindustrie-bw.de/en/article/press-release/unexpected-side-effect-how-common-medications-clear-way-pathogens
Press release - 18/07/2025 Faster sepsis diagnosis through hyperspectral imaging and AI Sepsis is one of the most dangerous medical emergencies. The condition is the result of a misdirected immune response to an infection, which can quickly lead to organ failure and death. Every hour counts – but early detection is difficult. A new study from Heidelberg now presents an innovative approach: artificial intelligence (AI) and hyperspectral imaging of the skin enable immediate and non-invasive sepsis diagnosis directly at the bedside.https://www.gesundheitsindustrie-bw.de/en/article/press-release/faster-sepsis-diagnosis-through-hyperspectral-imaging-and-ai
Press release - 15/07/2025 Mapping the metabolism of blood stem cells Researchers from the Max Planck Institute of Immunobiology and Epigenetics in Freiburg and ETH Zürich have created the first integrated map detailing the metabolic and molecular changes in human blood stem cells as they age, specialize, or turn cancerous. Their innovative research, made possible by highly sensitive low-input techniques, identifies the nutrient choline, as a key player in preserving youthful stem cell traits. https://www.gesundheitsindustrie-bw.de/en/article/press-release/mapping-metabolism-blood-stem-cells
Press release - 15/07/2025 Beyond health: The political effects of infectious disease outbreaks Do infectious disease outbreaks breed political mistrust? Ore Koren, Indiana University Bloomington (USA), and Nils Weidmann, University of Konstanz (Germany), have found out that they do. Their study was recently published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).https://www.gesundheitsindustrie-bw.de/en/article/press-release/beyond-health-political-effects-infectious-disease-outbreaks
Press release - 21/07/2025 Cancer Cachexia: Liver Identified as Driver of Body Wasting Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected. This wasting syndrome, affects around half of all cancer patients. Researchers from Helmholtz Munich, in collaboration with Heidelberg University Hospital, the Technical University of Munich, and the German Center for Diabetes Research, have now identified a previously overlooked driver of cachexia: the liver. https://www.gesundheitsindustrie-bw.de/en/article/press-release/cancer-cachexia-liver-identified-driver-body-wasting
Press release - 22/07/2025 Colorectal cancer in type 2 diabetes: An insightful look into the microenvironment of tumors Diabetics have a higher risk of colorectal cancer and often a poorer prognosis after developing the disease. The biological mechanisms behind this association were largely unknown. A research team at the German Cancer Research Center (DKFZ) has now discovered that tumors with a low number of immune cells appear to be particularly susceptible to the harmful effects of diabetes. https://www.gesundheitsindustrie-bw.de/en/article/press-release/colorectal-cancer-type-2-diabetes-insightful-look-microenvironment-tumors
Event - 14/10/2025 Clinical Trials in the Framework of MDR and FDA online, Webinar https://www.gesundheitsindustrie-bw.de/en/event/clinical-trials-framework-mdr-and-fda
Press release - 23/07/2025 Floppy and flexible: How Machine Learning helps to build new proteins A team of researchers from HITS and MPIP have developed a model that learns how to generate proteins whose structures are highly flexible, even with patterns that are uncommon in natural proteins. Their work, presented at the International Conference on Machine Learning (ICML), marks a step towards the goal of designing new proteins for applications in biotechnology, therapeutics and environmental research.https://www.gesundheitsindustrie-bw.de/en/article/press-release/floppy-and-flexible-how-machine-learning-helps-build-new-proteins
Press release - 23/07/2025 Study finds caffeine can weaken effectiveness of certain antibiotics ngredients of our daily diet – including caffeine – can influence the resistance of bacteria to antibiotics. This has been shown in a new study by a team of researchers at the Universities of Tübingen and Würzburg. They discovered bacteria such as E. coli orchestrate complex regulatory cascades to react to chemical stimuli from their direct environment which can influence the effectiveness of antimicrobial drugs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/study-finds-caffeine-can-weaken-effectiveness-certain-antibiotics
Press release - 24/07/2025 What makes cells migrate – and what can stop them Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body - not only during normal tissue formation and wound healing, but also when tumor cells metastasize. This makes the enzyme an interesting candidate for potential future therapeutic approaches.https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-makes-cells-migrate-and-what-can-stop-them
Press release - 24/07/2025 The origin of evil: stem cell-like cells are the reason for relapses of blood cancer in children and adolescents Stem cell-like leukemia cells are responsible for relapses in children and adolescents with a certain type of blood cancer, T-ALL. Researchers at the Hopp Children's Cancer Center Heidelberg (KiTZ), the Molecular Medicine Partnership Unit and the German Cancer Research Center were able to show this in a study. The results could help to overcome resistance in this form of blood cancer and prevent relapses.https://www.gesundheitsindustrie-bw.de/en/article/press-release/origin-evil-stem-cell-cells-are-reason-relapses-blood-cancer-children-and-adolescents
Press release - 24/07/2025 Solutions that minimise clinical waste and maximise recycling How can the transformation to increase sustainability in hospitals succeed? Participants in the SustainMed project presented their answers at the closing event on 27 June 2025 in Stuttgart. The Ministry of the Environment, Climate Protection and the Energy Sector Baden-Württemberg provided approximately 500,000 euros in funding to develop solutions for goals such as reducing volumes of waste in hospitals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/solutions-minimise-clinical-waste-and-maximise-recycling
Press release - 23/07/2025 Learning to save lives in the VR shock room Medical students train in virtual reality Medical students at Ulm University can train in a virtual shock room and practise treatment procedures regardless of time and place. Together with the company TriCAT, the Medical Faculty has created a virtual learning environment that is based on the real-life training shock room in the TTU training hospital. The benefit: through repeated training, students deepen their skills and become more confident in dealing with emergencies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/learning-save-lives-vr-shock-room-medical-students-train-virtual-reality
Event - 19/09/2025 40 years of the NMI - Open Day Reutlingen, Germany , Open Day https://www.gesundheitsindustrie-bw.de/en/event/40-years-nmi-open-day
Event - 07/10/2025 - 08/10/2025 HealthTech Innovation Days Paris, France, Innovation Day https://www.gesundheitsindustrie-bw.de/en/event/healthtech-innovation-days
Press release - 28/07/2025 New Max Planck Center with South Korea deepens biomedical research Scientists at the Max Planck Institutes for Medical Research in Heidelberg with its new departments based in Heilbronn, and for Neurobiology of Behavior – caesar in Bonn, and at the Institute for Basic Science at Yonsei University in Seoul will pool their expertise in future. The aim of the new Max Planck Center is to visualize cellular processes deep within human tissue and influence them in a targeted manner — without damaging the tissue.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-max-planck-center-south-korea-deepens-biomedical-research
Press release - 29/07/2025 New method to design custom protein binder Designing protein binders from scratch has long been a daunting challenge within the field of computational biology. Researchers have now developed an innovative, training-free pipeline that uses the fundamental principle of shape complementarity to design site-specific protein binders, which are then optimised to fit precisely onto chosen target sites. The researchers tested this on proteins linked to cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-method-design-custom-protein-binder
Press release - 01/08/2025 In science we trust? Six takeaways from a Science and Society conference EMBL's latest Science and Society conference brought together researchers, ethicists, communicators, policy professionals, and more to discuss the thorny question of trust in science.https://www.gesundheitsindustrie-bw.de/en/article/press-release/science-we-trust-six-takeaways-science-and-society-conference
Press release - 01/08/2025 A Less Debilitating Approach to Cancer Diagnosis Less radiation exposure during diagnosis and treatment for breast and lung cancer: New Fraunhofer method combines X-ray imaging and radar. In the MultiMed project, which explores multimodal medical imaging in 3D, researchers are developing a method that combines X-ray imaging and radar. It´s not only expected to improve the accuracy and efficacy of diagnosing, monitoring and treating breast and lung cancer but also lighten the burden on patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/less-debilitating-approach-cancer-diagnosis
Event - 04/02/2026 life – the biomedical convention 2026 Heidelberg, Germany, Event https://www.gesundheitsindustrie-bw.de/en/event/life-biomedical-convention-2026
Press release - 01/08/2025 Early Pancreatic Cancer Detection Tumors of the pancreas seldom cause symptoms in their early stages. This means that in many cases, they are not diagnosed until late, when the chances of successful treatment are poor. A new non-invasive diagnostic method designed by Fraunhofer researchers is set to make it possible to detect this aggressive form of cancer early on with high accuracy, significantly improving the prognosis for treatment.https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-pancreatic-cancer-detection
Press release - 04/08/2025 FOXP1 syndrome: Potential therapeutic approach discovered for rare language development disorder FOXP1 syndrome is a congenital disorder in which the brain development of affected children is severely impaired due to a genetic variant. A research team from the Medical Faculty Heidelberg at Heidelberg University has now demonstrated in mice, that the inhibition of a specific enzyme in the brain can improve abnormal behavior and immune cell dysfunction in the brain. The results have been published in the journal Advanced Science.https://www.gesundheitsindustrie-bw.de/en/article/press-release/foxp1-syndrome-potential-therapeutic-approach-discovered-rare-language-development-disorder
Press release - 05/08/2025 Playing Dominos: how an artificial protein emerges from fitting together individual components The targeted engineering of artificial proteins with unique properties – that is possible with the assistance of a novel method developed by a research team of Heidelberg University. It centers around a new AI model. This allows for forecasting how two proteins have to be fitted together at the molecular level from individual parts – subunits – in order to engineer a functional, adjustable new protein. https://www.gesundheitsindustrie-bw.de/en/article/press-release/playing-dominos-how-artificial-protein-emerges-fitting-together-individual-components
Funding Quantum Innovation Challenge 2025 Competition, Funded by: Novo Nordisk Foundation and Danish Business Authority, sb_search.searchresult.label.programSubmissionDate: 30/09/2025 https://www.gesundheitsindustrie-bw.de/en/database/funding/quantum-innovation-challenge-2025
Funding Quantum Innovation Challenge 2025 Competition, Funded by: Novo Nordisk Foundation and Danish Business Authority, sb_search.searchresult.label.programSubmissionDate: 30/09/2025 https://www.bio-pro.de/en/service/funding/quantum-innovation-challenge-2025
Breath test replaces invasive diagnostics - 30/07/2025 Novel smartphone sensor offers innovative breath test to detect Helicobacter infection The stomach bacterium Helicobacter pylori is widespread and, if left undetected, can impact our well-being and also lead to serious health conditions. While effective treatments exist, a reliable diagnosis is essential. To address this, researchers have developed an affordable breath test that uses a mini-sensor to detect the presence of the bacterium. They are currently working on a smartphone-compatible version for self-testing.https://www.gesundheitsindustrie-bw.de/en/article/news/novel-smartphone-sensor-offers-innovative-breath-test-detect-helicobacter-infection
Press release - 11/08/2025 The Cerebral Cortex Ages Less than Thought The human brain ages less than thought and in layers – at least in the area of the cerebral cortex responsible for the sense of touch. Researchers at DZNE, the University of Magdeburg, and the Hertie Institute for Clinical Brain Research at the University of Tübingen come to this conclusion based on brain scans of young and older adults in addition to studies in mice. https://www.gesundheitsindustrie-bw.de/en/article/press-release/cerebral-cortex-ages-less-thought
Event - 17/09/2025 - 18/09/2025 Life Sciences Baltics Vilnius, Lithuania, Conference https://www.gesundheitsindustrie-bw.de/en/event/life-sciences-baltics
Structured management of health data - 14/08/2025 Data governance in the healthcare sector The healthcare sector generates an increasing volume of data, yet much of it remains underutilised or inadequately secured. Implementing robust data governance - a structured framework for collecting, managing and protecting data - could unlock this untapped potential and lay the foundation for improved patient care.https://www.gesundheitsindustrie-bw.de/en/article/news/data-governance-healthcare-sector
Press release - 14/08/2025 Freezing brain tumor cells in a dormant state Every brain tumor is made up of cells in successive stages of activation. Researchers have now analyzed the individual structure of these activation pyramids in malignant brain tumors. In doing so, they discovered a signaling protein that slows down the transition from a dormant to an activated state by epigenetically reprogramming the cells. The hope is that this will permanently freeze cancer cells in a dormant state and thus halt tumor growth.https://www.gesundheitsindustrie-bw.de/en/article/press-release/freezing-brain-tumor-cells-dormant-state
Event - 25/08/2025 - 29/08/2025 Biotechgate Digital Partnering: Virtual business development & licensing event online, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/biotechgate-digital-partnering-virtual-business-development-und-licensing-event
Funding FIGHT KIDS CANCER 2025-2026 Call for proposals Funding programme, Funded by: European Science Foundation (ESF), sb_search.searchresult.label.programSubmissionDate: 17/10/2025 https://www.gesundheitsindustrie-bw.de/en/database/funding/fight-kids-cancer-2025-2026-call-proposals
Funding FIGHT KIDS CANCER 2025-2026 Call for proposals Funding programme, Funded by: European Science Foundation (ESF), sb_search.searchresult.label.programSubmissionDate: 17/10/2025 https://www.bio-pro.de/en/service/funding/fight-kids-cancer-2025-2026-call-proposals
Press release - 12/08/2025 Biomarkers for Brain Insulin Resistance Discovered in the Blood If the brain no longer responds properly to insulin (insulin resistance), this can lead to overweight, diabetes, and Alzheimer's disease. Researchers at the DZD in Potsdam and Tübingen have discovered small chemical modifications to genetic material (epigenetic changes*) in the blood that indicate how well the brain responds to insulin. These markers could help to detect insulin resistance in the brain – by means of a simple blood test.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biomarkers-brain-insulin-resistance-discovered-blood
The Baden-Württemberg healthcare industry Medical technology Medical technology plays a key role in health and makes a contribution to improving quality of life. The spectrum of medical technology ranges from disposable products, IT-based applications to innovative technologies. In Baden-Württemberg, 836 companies are active in research, development and/or production in this field, making medical technology one of the most important economic sectors in the state.https://www.gesundheitsindustrie-bw.de/en/location/medtech
Overview The Phytopharmaceuticals and Valuable Plant Ingredients initiative The Phytopharmaceuticals and Valuable Plant Ingredients initiative aims to further develop phytopharmaceuticals and valuable plant ingredients in Baden-Württemberg.https://www.bio-pro.de/en/projects/Completed-projects/phytopharmaceuticals-and-valuable-plant-ingredients-initiative
Press release - 21/08/2025 Ultrafast Pace in the Brain: New Insights into Calcium Transport and Signal Processing Researchers at the University of Freiburg, together with partners, have uncovered the mechanism of ultrafast transport by calcium pumps in nerve cells. These pumps, complexes of PMCA2 and neuroplastin proteins, operate at more than 5,000 cycles per second and terminate calcium signals within milliseconds – 100 times faster than previously known. They play a crucial role in rapid information processing in the brain. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ultrafast-pace-brain-new-insights-calcium-transport-and-signal-processing
Press release - 14/08/2025 Speeding up long-term memory Svenja Brodt uses MRI brain scans to investigate how impressions become memories. A better understanding of how long-term memories are formed could help Alzheimer's patients cope with their daily lives. Impaired memory formation could be compensated for by targeted repetition.https://www.gesundheitsindustrie-bw.de/en/article/press-release/speeding-long-term-memory
Press release - 21/08/2025 Nanodroplets Could Speed Up the Search for New Medicine Until now, the early phase of drug discovery for the development of new therapeutics has been cost- and time-intensive. Researchers at KIT have developed a platform on which extremely miniaturized nanodroplets with a volume of 200 nanoliters per droplet and containing 300 cells per test can be arranged. This platform enables the researchers to synthesize and test thousands of therapeutic agents on the same chip, saving time and resources. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanodroplets-could-speed-search-new-medicine
Press release - 26/08/2025 Key mechanism for Alzheimer's disease discovered A molecular mechanism that contributes to the progression of Alzheimer’s disease has been discovered by a research team of Heidelberg University. The team, using an Alzheimer’s mouse model, demonstrated that a neurotoxic protein-protein complex is responsible for nerve cells in the brain dying off and the resulting cognitive decline. This finding opens up new perspectives for the development of effective treatments.https://www.gesundheitsindustrie-bw.de/en/article/press-release/key-mechanism-alzheimers-disease-discovered
Enhancing human perception of the imperceptible - 28/08/2025 AI-driven imaging expands possibilities in surgery Doctors frequently experience a restricted view of the surgical field, particularly during endoscopic procedures. A novel technique developed by Prof. Dr. Lena Maier-Hein's team at the DKFZ in Heidelberg integrates spectral imaging with AI-driven data analysis. This innovation facilitates accurate tissue differentiation and delivers real-time insights into organ function.https://www.gesundheitsindustrie-bw.de/en/article/news/ai-driven-imaging-expands-possibilities-surgery
Press release - 28/08/2025 Inhibition of cell division induces immunoreactive peptides in cancer cells A team of scientists from the German Cancer Research Center (DKFZ) and the Netherlands Cancer Institute has discovered a previously unknown vulnerability in cancer cells: When cell division is blocked with chemotherapeutic agents such as Taxol, cancer cells produce small immunogenic peptides that could open up new avenues for immune-based cancer therapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/inhibition-cell-division-induces-immunoreactive-peptides-cancer-cells
Press release - 29/08/2025 Sleeping beauties: the biology behind oocyte dormancy The maturation process of oocytes remains paused for several years. Researchers from Konstanz and Göttingen have now found out which protein ensures this state is maintained over such a long period.https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleeping-beauties-biology-behind-oocyte-dormancy
Press release - 03/09/2025 Therapeutic vaccination against HPV-related tumors: Nanoparticles make the difference Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg University to develop a therapeutic vaccination concept that can mobilize the immune system to target cancer cells. The team showed that virus peptides coupled to silica nanoparticles can elicit effective T-cell responses against HPV-related tumors. https://www.gesundheitsindustrie-bw.de/en/article/press-release/therapeutic-vaccination-against-hpv-related-tumors-nanoparticles-make-difference
Press release - 03/09/2025 Nature publication: Mechanical tensions as a driver of evolution When embryos grow, cells and tissue are constantly bumping into each other. This creates mechanical tensions that could endanger their development. A team from University of Hohenheim and the Japanese RIKEN Center have discovered that fly embryos have strategies to deal with this pressure. The different species have developed two different solutions. This ability to control mechanical tension could be a key to why so many body plans have evolved.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nature-publication-mechanical-tensions-driver-evolution
Press release - 08/09/2025 New and simple detection method for nanoplastics A joint team from the University of Stuttgart in Germany and the University of Melbourne in Australia has developed a new method for the straightforward analysis of tiny nanoplastic particles in environmental samples. One needs only an ordinary optical microscope and a newly developed test strip—the optical sieve. The research results have now been published in “Nature Photonicshttps://www.gesundheitsindustrie-bw.de/en/article/press-release/new-and-simple-detection-method-nanoplastics
Press release - 04/09/2025 Fraunhofer researchers develop innovative diagnostics for detecting antibiotic resistance in bacterial infections The rapid increase in antibiotic-resistant bacteria is one of the most pressing challenges facing global health. A new transatlantic Fraunhofer research project aims to counter these threats with an innovative diagnostic approach: a microfluidic rapid test system using carbon nanotubes (SWCNT) will make bacterial resistance visible in just a few minutes, significantly faster than conventional methods.https://www.gesundheitsindustrie-bw.de/en/article/press-release/fraunhofer-researchers-develop-innovative-diagnostics-detecting-antibiotic-resistance-bacterial-infections
Press release - 04/09/2025 Rare bone tumors: Tailor-made mini-proteins switch off tumor drivers Chordomas are rare bone tumors for which there are no effective drugs. A research team from the DKFZ and the NCT Heidelberg has now developed a promising approach: Tailor-made mini-proteins specifically block the driver of tumor development. In the result, slowing the growth of chordoma cells in the laboratory and in a mouse model, while also revealing further molecular vulnerabilities of the tumor that could be addressed with approved drugs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/rare-bone-tumors-tailor-made-mini-proteins-switch-tumor-drivers-1
Fluorescence and smartphones instead of laboratories - 11/09/2025 Mobile blood-analysis system for at home medication monitoring For many medications, regular monitoring of drug concentrations in the blood is necessary to ensure efficacy and safety. Until now, this process has been time-consuming and required laboratory personnel and resources. The Heidelberg based start up QuantiLight has developed a mobile device with innovative sensor technology that enables quick, easy measurements at home or in a doctor's surgery.https://www.gesundheitsindustrie-bw.de/en/article/news/mobile-blood-analysis-system-home-medication-monitoring